Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Serum triglycerides as a risk factor for atherosclerosis].

A F Stalenhoef1

  • 1Academisch Ziekenhuis, afd. Algemeen Interne Geneeskunde, Nijmegen.

Nederlands Tijdschrift Voor Geneeskunde
|April 30, 1999
PubMed
Summary

Plasma triglycerides are linked to coronary artery disease (CAD) risk, but the relationship is complex. Optimal levels (<1.1 mmol/l) show reduced risk, while intermediate levels (1.1-4 mmol/l) indicate higher CAD risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of Concentrated n-3 Fatty Acids in Hypertriglyceridaemia : A Comparison with Gemfibrozil.

Clinical drug investigation·2016
Same author

Rationale, Design and Baseline Characteristics of a Clinical Trial Comparing the Effects of Robust vs Conventional Cholesterol Lowering and Intima Media Thickness in Patients with Familial Hypercholesterolaemia : The Atorvastatin versus Simvastatin on Atherosclerosis Progression (ASAP) Study.

Clinical drug investigation·2013
Same author

Serum triglycerides and risk of cardiovascular disease.

Biochimica et biophysica acta·2011
Same author

Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin.

The pharmacogenomics journal·2011
Same author

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.

Journal of internal medicine·2006
Same author

Effects of pioglitazone in familial combined hyperlipidaemia.

Journal of internal medicine·2005

Area of Science:

  • Cardiovascular Medicine
  • Lipid Metabolism
  • Biochemistry

Context:

  • The role of plasma triglycerides in coronary artery disease (CAD) development has been debated.
  • Triglyceride's predictive value for CAD is often attenuated by high-density lipoprotein (HDL) cholesterol.
  • Lipoprotein metabolism complexity contributes to the ongoing controversy.

Purpose:

  • To clarify the complex relationship between plasma triglyceride levels and coronary artery disease (CAD) risk.
  • To elucidate the nuanced impact of varying triglyceride concentrations on cardiovascular health.
  • To reconcile conflicting findings regarding triglycerides as CAD risk factors.

Summary:

  • Plasma triglycerides serve as indicators for metabolic conditions associated with elevated CAD risk.
  • Recent research indicates a non-linear association between triglyceride levels and CAD risk.
  • An optimal plasma triglyceride concentration is suggested to be below 1.1 mmol/l, with increased risk in the 1.1-4 mmol/l range, and decreasing risk above this threshold.

Impact:

  • Provides a clearer understanding of triglyceride's role in CAD pathogenesis.
  • Highlights the importance of considering specific triglyceride concentration ranges for risk assessment.
  • Informs clinical practice regarding lipid management and cardiovascular risk stratification.

Related Experiment Videos